SEARCH

SEARCH BY CITATION

References

  • 1
    Bucaneve G, Micozzi A, Menichetti F et al. Levofloxacin to prevent bacterial infection in patients with cancer and neutropenia. N Eng J Med 2005; 10: 977987.
  • 2
    Feld R. Bloodstream infections in cancer patients with febrile neutropenia. Int J Antimicro A 2008; 32: 3033.
  • 3
    Zinner SH. Changing epidemiology of infections in patients with neutropenia and cancer : emphasis of Gram-positive and resistant bacteria. Clin Infect Dis 1999; 29: 490494.
  • 4
    Elouennass M, Foissaud V, Trueba F et al. A 7-year survey of strains identified in blood cultures in a clinical haematology unit. Med Mal 2004; 34: 6269.
  • 5
    Freifeld AG, Bow EJ, Sepkowitz KA et al. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 Update by the Infectious Diseases Society of America. Clin Infect Dis 2011; 52: 427431.
  • 6
    Mikulska M, Akova M, Averbuch D et al. Epidemiology of bacterial infections and antimicrobial resistance in haematological cancer patients. ECIL 2012: 4Th European Conference on infections in leukemia.
  • 7
    Swerdlow SH, Campo E, Haris NL et al. WHO Classification of tumours of hematopoietic and lymphoid tissues. Lyon: Edition International Agency for Research on Cancer, 2008
  • 8
    Agence nationale de sécurité du médicament et des produits de santé. Utilisation de préparation hospitalière dans la décontamination digestive sélective. Available from www.ansm.sante.fr (last accessed 12 October 2012).
  • 9
    Blot F, Nitenberg G, Chachaty E et al. Diagnosis of catheter-related bacteraemia: a prospective comparison of the time to positivity of hub-blood versus peripheral-blood cultures. Lancet 1999; 25: 10711077.
  • 10
    Cordonnier C, Herbrecht R, Buzyn A et al. Risk factors for Gram-negative bacterial infections in febrile neutropenia. Haematologica 2005; 90: 11021109.
  • 11
    Legrand M, Max A, Peigne V et al. Survival in neutropenic patients with severe sepsis or septic shock. Crit Care Med 2012; 40: 4349.
  • 12
    Albrecht SJ, Fishman NO, Kitchen J et al. Reemergence of gram negative health care-associated bloodstream infections. Arch Intern Med 2006; 166: 12891294.
  • 13
    Luzzaro F, Ortisi G, Larosa M, Drago M, Brigante G, Gesu G. Prevalence and epidemiology of microbial pathogens causing bloodstream infections:results of the OASIS multicenter study. Diag Micro Infect Dis 2011; 69: 363369.
  • 14
    Biedenbach DJ, Moet GJ, Jones RN. Occurrence and antimicrobial resistance pattern comparisons among bloodstream infection isolates from the Sentry antimicrobial surveillance program. Diag Microbiol Infect Dis 2004; 50: 5669.
  • 15
    Marra AR, Camargo L, Pignatari A et al. Nosocomial bloodstream infections in Brazilian hospitals: analysis of 2563 cases from a prospective nationwide surveillance study. J Clin Microbiol 2011; 49: 18661871.
  • 16
    Gupta A, Singh M, Singh H et al. Infections in acute myeloid leukemia: an analysis of 382 febrile episodes. Med Oncol 2010; 27: 10371045.
  • 17
    Cattaneo C, Quaresmini G, Casari S et al. Recent changes in bacterial epidemiology and the emergence of fluoroquinolone-resistant Escherichia coli among patients with haematological malignancies: results of a prospective study on 823 patients at a single institution. J Antimicrob Chemother 2008; 61: 721728.
  • 18
    Cattaneo C, Antoniazzi F, Casari S, Ravizzola G. P. aeruginosa bloodstream infections among haematological patients: an old or new question ? Ann Hematol 2012; 91: 12991304.
  • 19
    Elmaataoui A, Elghazouani M, Akwa EN et al. Blood isolates epidemiology in a clinical haematology department. Ann Biol Clin 2009; 67: 293297.
  • 20
    Baskaran ND, Gan GG, Adeeba K, Sam IC. Bacteremia in patients with febrile neutropenia after chemotherapy at a university medical center in Malaysia. Int J Int Dis 2007; 11: 513517.
  • 21
    Infectious diseases Society of America. Morbididy and mortality weekly report. Recommendations of CDC, ASBMT, October 2000.
  • 22
    Araoka H, Baba M, Yoneyama A. Risk factors for mortalitu among patients with Stenotrophomonas maltophilia bacteremia in Tokyo, Japan, 1966-2009. Eur J Clin Microbiol Infect Dis 2010; 29: 605608.
  • 23
    Viscoli C, Castagnola E. Treatment of febrile neutropenia: what is new ? Curr Opin Infect Dis 2002; 15: 377382.
  • 24
    Zahar JR, Farhat H, Chachaty E, Meshaka P, Antoun S, Nitenberg G. Incidence and clinical significance of anaerobic bacteraemia in cancer patients: a 6 year retrospective study. Eur Soc Clin Microbiol Infect Dis 2005; 11: 724729.
  • 25
    Interscience conference on antimicrobial agents and chemotherapy. Available from www.icaac.org (last accessed 12 December 2012).
  • 26
    Sanmartin N, Martinaud C, Konopacki J et al. Interest for quantitative stool culture for patients with bone marrow transplantation: a retrospective study 2003-2010 in HIA Percy. Oral communication. Réunion interdisciplinaire de chimiothérapie antiinfectieuse, Novembre 2012, Paris.
  • 27
    Daw MA, Munnelly P, McCann SR, Daly PA, Falkiner FR, Keane CT. Value of surveillance cultures in the management of neutropenic patients. Eur J Clin Microbio Infect Dis 1988; 7: 742747.
  • 28
    European Centre for Disease Prevention and Control. Antimicrobial resistance surveillance in Europe, annual report 2010. Available from www.ecdc.europa.eu (last accessed 05 October 2013).
  • 29
    Observatoire national de l'épidémiologie de la résistance bactérienne aux antibiotiques. Available from www.onerba.org (last accessed 10 January 2013).
  • 30
    Decousser JW, Lamy B, Pina P, Allouch PY. Trends in antibiotic susceptibility of bloodstream pathogens in hospitalized patients in France, 1996 to 2007. Diag Micro Infect Dis 2010; 66: 292300.
  • 31
    Paris-Nord Nosocomial Infection Prevention Coordinating Committee. Available from www.cclinparisnord.org (last accessed 20 January 13).